Published on: 22 July 2021 [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good half-year results more
Published on: 21 July 2021 FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes more
125 Years Celebrate Life Learn more about Roche’s 125 year anniversary and the Celebrate Life campaign more
